Grandeur Peak Global Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-4,275
Closed -$295K – 116
2020
Q2
$295K Sell
4,275
-9,525
-69% -$677K 0.02% 104
2020
Q1
$868K Sell
13,800
-525
-4% -$37.9K 0.09% 92
2019
Q4
$1.11M Hold
14,325
– – 0.1% 75
2019
Q3
$1.05M Sell
14,325
-2,700
-16% -$190K 0.11% 78
2019
Q2
$1.05M Hold
17,025
– – 0.11% 72
2019
Q1
$1.09M Sell
17,025
-20,775
-55% -$1.19M 0.12% 71
2018
Q4
$1.93M Sell
37,800
-5,400
-13% -$273K 0.25% 64
2018
Q3
$2.51M Buy
43,200
+750
+2% +$36.7K 0.26% 68
2018
Q2
$2.06M Sell
42,450
-2,400
-5% -$112K 0.21% 70
2018
Q1
$2.09M Sell
44,850
-300
-0.7% -$13K 0.24% 72
2017
Q4
$1.7M Buy
45,150
+2,325
+5% +$85.3K 0.22% 67
2017
Q3
$1.56M Buy
42,825
+3,075
+8% +$117K 0.24% 61
2017
Q2
$1.57M Buy
39,750
+3,000
+8% +$110K 0.23% 68
2017
Q1
$1.15M Buy
36,750
+11,400
+45% +$357K 0.19% 69
2016
Q4
$792K Buy
+25,350
New +$821K 0.15% 78

Other funds holding EW

Grandeur Peak Global Advisors's EW Position: Q3 2020 in Review

Grandeur Peak Global Advisors sold out of Edwards Lifesciences (EW) in Q3 2020, closing a stake of 4,275 shares — an estimated $295K sold.

Grandeur Peak Global Advisors first reported a position in EW in Q4 2016 and held it in 15 quarters. The position peaked at $2.51M in Q3 2018. 1,083 funds tracked by Wall St. Rank hold EW as of Q3 2020.

  • Grandeur Peak Global Advisors reported no remaining Edwards Lifesciences position as of Q3 2020 after selling out during the quarter.
  • Grandeur Peak Global Advisors sold 4,275 Edwards Lifesciences shares in Q3 2020, an estimated $295K.
  • Grandeur Peak Global Advisors first reported a position in Edwards Lifesciences in Q4 2016 and held it in 15 quarters.
  • Grandeur Peak Global Advisors's Edwards Lifesciences position peaked at $2.51M in Q3 2018.
  • 1,083 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2020.

Based on Grandeur Peak Global Advisors's 13F filing for Q3 2020, filed 17 Nov 2020.